Company No:
Contents
| Note | 2025 | 2024 | ||
| £ | £ | |||
| Fixed assets | ||||
| Tangible assets | 3 |
|
|
|
| 9,016,219 | 9,016,219 | |||
| Current assets | ||||
| Debtors | 4 |
|
|
|
| Cash at bank and in hand | 5 |
|
|
|
| 174,425 | 317,216 | |||
| Creditors: amounts falling due within one year | 6 | (
|
(
|
|
| Net current assets | 101,099 | 260,392 | ||
| Total assets less current liabilities | 9,117,318 | 9,276,611 | ||
| Provision for liabilities | 7 | (
|
(
|
|
| Net assets |
|
|
||
| Capital and reserves | ||||
| Called-up share capital | 8 |
|
|
|
| Revaluation reserve |
|
|
||
| Profit and loss account |
|
|
||
| Total shareholders' funds |
|
|
Directors' responsibilities:
The financial statements of More Surgical Services Limited (registered number:
|
A D Chancellor-Weale
Director |
The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.
More Surgical Services Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 108 Harley Street, London, W1G 7ET, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.
Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.
Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.
The fair value is determined annually by the directors, on an open market value for existing use basis.
The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Balance Sheet date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).
When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.
Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.
| 2025 | 2024 | ||
| Number | Number | ||
| Monthly average number of persons employed by the Company during the year, including directors |
|
|
| Investment property | Total | ||
| £ | £ | ||
| Cost | |||
| At 01 July 2024 |
|
|
|
| At 30 June 2025 |
|
|
|
| Accumulated depreciation | |||
| At 01 July 2024 |
|
|
|
| At 30 June 2025 |
|
|
|
| Net book value | |||
| At 30 June 2025 | 9,016,219 | 9,016,219 | |
| At 30 June 2024 | 9,016,219 | 9,016,219 |
Revaluation of tangible assets
If the Investment properties had been accounted for under the historic cost accounting rules, the properties would have been measured as below.
| 2025 | 2024 | ||
| £ | £ | ||
| Historical cost | 1,249,995 | 1,249,995 | |
| Carrying value |
|
|
| 2025 | 2024 | ||
| £ | £ | ||
| Prepayments |
|
|
|
| Other debtors |
|
|
|
|
|
|
| 2025 | 2024 | ||
| £ | £ | ||
| Cash at bank and in hand |
|
|
| 2025 | 2024 | ||
| £ | £ | ||
| Accruals and deferred income |
|
|
|
| Corporation tax |
|
|
|
| Other taxation and social security |
|
|
|
| Other creditors |
|
|
|
|
|
|
| 2025 | 2024 | ||
| £ | £ | ||
| At the beginning of financial year | (
|
(
|
|
| Charged to the Profit and Loss Account |
|
(
|
|
| At the end of financial year | (
|
(
|
The deferred taxation balance is made up as follows:
| 2025 | 2024 | ||
| £ | £ | ||
| Revaluation of investment property | (
|
(
|
| 2025 | 2024 | ||
| £ | £ | ||
| Allotted, called-up and fully-paid | |||
|
|
|
|
Other related party transactions
| 2025 | 2024 | ||
| £ | £ | ||
| Rent charged to 108 Medical Limited | 312,000 | 245,000 |